martes, 31 de octubre de 2023

FDA approves toripalimab-tpzi for nasopharyngeal carcinoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-toripalimab-tpzi-nasopharyngeal-carcinoma

No hay comentarios:

Publicar un comentario